Functional hepatocytes derived from human pluripotent stem cells (hPSCs) have potential as tools for predicting drug-induced hepatotoxicity in the early phases of drug development. However, the propensity of hPSC lines to differentiate into specific lineages is reported to differ. The ability to predict low propensity of hPSCs to differentiate into hepatocytes would facilitate the selection of useful hPSC clones and substantially accelerate development of hPSC-derived hepatocytes for pharmaceutical research. In this study, we compared the expression of genes associated with hepatic differentiation in five hPSC lines including human ES cell line, H9, which is known to differentiate into hepatocytes, and an hPSC line reported with a poor propensity for hepatic differentiation. Genes distinguishing between undifferentiated hPSCs, hPSC-derived hepatoblast-like differentiated cells, and primary human hepatocytes were drawn by two-way cluster analysis. The order of expression levels of genes in undifferentiated hPSCs was compared with that in hPSC-derived hepatoblast-like cells. Three genes were selected as predictors of low propensity for hepatic differentiation. Expression of these genes was investigated in 23 hPSC clones. Review of representative cells by induction of hepatic differentiation suggested that low prediction scores were linked with low hepatic differentiation. Thus, our model using gene expression ranking and bioinformatic analysis could reasonably predict poor differentiation propensity of hPSC lines.
Get full access to this article
View all access options for this article.
References
1.
ThomsonJA, Itskovitz-EldorJ, ShapiroSS, WaknitzMA, SwiergielJJ, MarshallVS and JonesJM. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
2.
TakahashiK and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.
3.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
4.
MurryCE and KellerG. (2008). Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell, 132:661–680.
5.
BarbaricI, GokhalePJ and AndrewsPW. (2010). High-content screening of small compounds on human embryonic stem cells. Biochem Soc Trans, 38:1046–1050.
6.
EngleSJ and PuppalaD. (2013). Integrating human pluripotent stem cells into drug development. Cell Stem Cell, 12:669–677.
7.
HeslopJA, RoweC, WalshJ, Sison-YoungR, JenkinsR, KamalianL, KiaR, HayD, JonesRP, et al. (2016). Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile. Arch Toxicol [Epub ahead of print]; DOI:10.1007/s00204-016-1694-y.
8.
RashidST, CorbineauS, HannanN, MarciniakSJ, MirandaE, AlexanderG, Huang-DoranI, GriffinJ, Ahrlund-RichterL, et al. (2010). Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest, 120:3127–3136.
9.
CayoMA, CaiJ, DeLaForestA, NotoFK, NagaokaM, ClarkBS, ColleryRF, Si-TayebK and DuncanSA. (2012). JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia. Hepatology, 56:2163–2171.
10.
RoelandtP, ObeidS, PaeshuyseJ, VanhoveJ, Van LommelA, NahmiasY, NevensF, NeytsJ and VerfaillieCM. (2012). Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. J Hepatol, 57:246–251.
11.
WuX, RobothamJM, LeeE, DaltonS, KnetemanNM, GilbertDM and TangH. (2012). Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog, 8:e1002617.
12.
ZhouX, SunP, Lucendo-VillarinB, AngusAG, SzkolnickaD, CameronK, FarnworthSL, PatelAH and HayDC. (2014). Modulating innate immunity improves hepatitis C virus infection and replication in stem cell-derived hepatocytes. Stem Cell Reports, 3:204–214.
13.
SullivanGJ, HayDC, ParkIH, FletcherJ, HannounZ, PayneCM, DalgettyD, BlackJR, RossJA, et al. (2010). Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology, 51:329–335.
14.
AnsonBD, KolajaKL and KampTJ. (2011). Opportunities for use of human iPS cells in predictive toxicology. Clin Pharmacol Ther, 89:754–758.
HolmgrenG, SjogrenAK, BarraganI, SabirshA, SartipyP, SynnergrenJ, BjorquistP, Ingelman-SundbergM, AnderssonTB and EdsbaggeJ. (2014). Long-term chronic toxicity testing using human pluripotent stem cell-derived hepatocytes. Drug Metab Dispos, 42:1401–1406.
17.
SzkolnickaD, FarnworthSL, Lucendo-VillarinB, StorckC, ZhouW, IredaleJP, FlintO and HayDC. (2014). Accurate prediction of drug-induced liver injury using stem cell-derived populations. Stem Cells Transl Med, 3:141–148.
18.
SzkolnickaD, Lucendo-VillarinB, MooreJK, SimpsonKJ, ForbesSJ and HayDC. (2016). Reducing hepatocyte injury and necrosis in response to paracetamol using noncoding RNAs. Stem Cells Transl Med, 5:764–772.
19.
RashidiH, AlhaqueS, SzkolnickaD, FlintO and HayDC. (2016). Fluid shear stress modulation of hepatocyte-like cell function. Arch Toxicol, 90:1757–1761.
LavonN, YanukaO and BenvenistyN. (2004). Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation, 72:230–238.
22.
DuanY, CatanaA, MengY, YamamotoN, HeS, GuptaS, GambhirSS and ZernMA. (2007). Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells, 25:3058–3068.
23.
HayDC, ZhaoD, RossA, MandalamR, LebkowskiJ and CuiW. (2007). Direct differentiation of human embryonic stem cells to hepatocyte-like cells exhibiting functional activities. Cloning Stem Cells, 9:51–62.
24.
HayDC, FletcherJ, PayneC, TerraceJD, GallagherRC, SnoeysJ, BlackJR, WojtachaD, SamuelK, et al. (2008). Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci U S A, 105:12301–12306.
25.
FletcherJ, CuiW, SamuelK, BlackJR, HannounZ, CurrieIS, TerraceJD, PayneC, FilippiC, et al. (2008). The inhibitory role of stromal cell mesenchyme on human embryonic stem cell hepatocyte differentiation is overcome by Wnt3a treatment. Cloning Stem Cells, 10:331–339.
26.
AgarwalS, HoltonKL and LanzaR. (2008). Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells, 26:1117–1127.
27.
HayDC, ZhaoD, FletcherJ, HewittZA, McLeanD, Urruticoechea-UriguenA, BlackJR, ElcombeC, RossJA, WolfR and CuiW. (2008). Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo. Stem Cells, 26:894–902.
28.
ShirakiN, UmedaK, SakashitaN, TakeyaM, KumeK and KumeS. (2008). Differentiation of mouse and human embryonic stem cells into hepatic lineages. Genes Cells, 13:731–746.
29.
SongZ, CaiJ, LiuY, ZhaoD, YongJ, DuoS, SongX, GuoY, ZhaoY, et al. (2009). Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res, 19:1233–1242.
30.
TouboulT, HannanNR, CorbineauS, MartinezA, MartinetC, BranchereauS, MainotS, Strick-MarchandH, PedersenR, et al. (2010). Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology, 51:1754–1765.
31.
Si-TayebK, NotoFK, NagaokaM, LiJ, BattleMA, DurisC, NorthPE, DaltonS and DuncanSA. (2010). Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology, 51:297–305.
32.
GodoyP, Schmidt-HeckW, NatarajanK, Lucendo-VillarinB, SzkolnickaD, AsplundA, BjorquistP, WideraA, StoberR, et al. (2015). Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells. J Hepatol, 63:934–942.
33.
CameronK, TanR, Schmidt-HeckW, CamposG, LyallMJ, WangY, Lucendo-VillarinB, SzkolnickaD, BatesN, et al. (2015). Recombinant laminins drive the differentiation and self-organization of hESC-derived hepatocytes. Stem Cell Reports, 5:1250–1262.
34.
InamuraM, KawabataK, TakayamaK, TashiroK, SakuraiF, KatayamaK, ToyodaM, AkutsuH, MiyagawaY, et al. (2011). Efficient generation of hepatoblasts from human ES cells and iPS cells by transient overexpression of homeobox gene HEX. Mol Ther, 19:400–407.
35.
TakayamaK, InamuraM, KawabataK, TashiroK, KatayamaK, SakuraiF, HayakawaT, FurueMK and MizuguchiH. (2011). Efficient and directive generation of two distinct endoderm lineages from human ESCs and iPSCs by differentiation stage-specific SOX17 transduction. PLoS One, 6:e21780.
36.
NagamotoY, TashiroK, TakayamaK, OhashiK, KawabataK, SakuraiF, TachibanaM, HayakawaT, FurueMK and MizuguchiH. (2012). The promotion of hepatic maturation of human pluripotent stem cells in 3D co-culture using type I collagen and Swiss 3T3 cell sheets. Biomaterials, 33:4526–4534.
37.
TakayamaK, InamuraM, KawabataK, KatayamaK, HiguchiM, TashiroK, NonakaA, SakuraiF, HayakawaT, FurueMK and MizuguchiH. (2012). Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4alpha transduction. Mol Ther, 20:127–137.
38.
TakayamaK, InamuraM, KawabataK, SugawaraM, KikuchiK, HiguchiM, NagamotoY, WatanabeH, TashiroK, et al. (2012). Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1alpha transduction. J Hepatol, 57:628–636.
39.
WatanabeH, TakayamaK, InamuraM, TachibanaM, MimuraN, KatayamaK, TashiroK, NagamotoY, SakuraiF, et al. (2014). HHEX promotes hepatic-lineage specification through the negative regulation of eomesodermin. PLoS One, 9:e90791.
40.
TashiroK, KawabataK, InamuraM, TakayamaK, FurukawaN, SakuraiF, KatayamaK, HayakawaT, FurueMK and MizuguchiH. (2010). Adenovirus vector-mediated efficient transduction into human embryonic and induced pluripotent stem cells. Cell Reprogram, 12:501–507.
41.
International Stem Cell Initiative, AdewumiO, AflatoonianB, Ahrlund-RichterL, AmitM, AndrewsPW, BeightonG, BelloPA, BenvenistyN, BerryLS, et al. (2007). Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol, 25:803–816.
42.
OsafuneK, CaronL, BorowiakM, MartinezRJ, Fitz-GeraldCS, SatoY, CowanCA, ChienKR and MeltonDA. (2008). Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol, 26:313–315.
43.
BockC, KiskinisE, VerstappenG, GuH, BoultingG, SmithZD, ZillerM, CroftGF, AmorosoMW, et al. (2011). Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell, 144:439–452.
44.
MullerFJ, SchuldtBM, WilliamsR, MasonD, AltunG, PapapetrouEP, DannerS, GoldmannJE, HerbstA, et al. (2011). A bioinformatic assay for pluripotency in human cells. Nat Methods, 8:315–317.
45.
Koyanagi-AoiM, OhnukiM, TakahashiK, OkitaK, NomaH, SawamuraY, TeramotoI, NaritaM, SatoY, et al. (2013). Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc Natl Acad Sci U S A, 110:20569–20574.
46.
BaxterM, WitheyS, HarrisonS, SegeritzCP, ZhangF, Atkinson-DellR, RoweC, GerrardDT, Sison-YoungR, et al. (2015). Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes. J Hepatol, 62:581–589.
47.
KajiwaraM, AoiT, OkitaK, TakahashiR, InoueH, TakayamaN, EndoH, EtoK, ToguchidaJ, UemotoS and YamanakaS. (2012). Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci U S A, 109:12538–12543.
48.
LeeSB, SeoD, ChoiD, ParkKY, HolczbauerA, MarquardtJU, ConnerEA, FactorVM and ThorgeirssonSS. (2012). Contribution of hepatic lineage stage-specific donor memory to the differential potential of induced mouse pluripotent stem cells. Stem Cells, 30:997–1007.
49.
IshikawaT, KobayashiM, YanagiS, KatoC, TakashimaR, KobayashiE, HagiwaraK and OchiyaT. (2015). Human induced hepatic lineage-oriented stem cells: autonomous specification of human iPS cells toward hepatocyte-like cells without any exogenous differentiation factors. PLoS One, 10:e0123193.
50.
ItabaN, WairaguPM, AramakiN, YasuiT, MatsumiY, KonoY, PhanAN, OtsuM, KunisadaT, et al. (2014). Nuclear receptor gene alteration in human induced pluripotent stem cells with hepatic differentiation propensity. Hepatol Res, 44:E408–E419.
51.
AmitM, CarpenterMK, InokumaMS, ChiuCP, HarrisCP, WaknitzMA, Itskovitz-EldorJ and ThomsonJA. (2000). Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol, 227:271–278.
52.
NishinoK, ToyodaM, Yamazaki-InoueM, FukawataseY, ChikazawaE, SakaguchiH, AkutsuH and UmezawaA. (2011). DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet, 7:e1002085.
53.
KineharaM, KawamuraS, TateyamaD, SugaM, MatsumuraH, MimuraS, HirayamaN, HirataM, Uchio-YamadaK, et al. (2013). Protein kinase C regulates human pluripotent stem cell self-renewal. PLoS One, 8:e54122.
54.
FurueMK and KineharaM. (KYOWA HAKKO BIO CO., LTD., JAPAN). Method for culturing human pluripotent stem cells. PCT/JP2011/004691, WO2012104936A1
55.
FurueMK, NaJ, JacksonJP, OkamotoT, JonesM, BakerD, HataR, MooreHD, SatoJD and AndrewsPW. (2008). Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proc Natl Acad Sci U S A, 105:13409–13414.
56.
KineharaM, KawamuraS, MimuraS, SugaM, HamadaA, WakabayashiM, NikawaH and FurueMK. (2014). Protein kinase C-induced early growth response protein-1 binding to SNAIL promoter in epithelial-mesenchymal transition of human embryonic stem cells. Stem Cells Dev, 23:2180–2189.
57.
MimuraS, SugaM, LiuY, KineharaM, YanagiharaK, OhnumaK, NikawaH and FurueMK. (2015). Synergistic effects of FGF-2 and Activin A on early neural differentiation of human pluripotent stem cells. In Vitro Cell Dev Biol Anim, 51:769–775.
58.
MimuraS, SugaM, OkadaK, KineharaM, NikawaH and FurueMK. (2016). Bone morphogenetic protein 4 promotes craniofacial neural crest induction from human pluripotent stem cells. Int J Dev Biol, 60:21–28.
59.
HannanNR, FordhamRP, SyedYA, MoignardV, BerryA, BautistaR, HanleyNA, JensenKB and VallierL. (2013). Generation of multipotent foregut stem cells from human pluripotent stem cells. Stem Cell Reports, 1:293–306.
60.
CaiJ, DeLaForestA, FisherJ, UrickA, WagnerT, TwaroskiK, CayoM, NagaokaM and Duncan.SA (2012). Protocol for directed differentiation of human pluripotent stem cells toward a hepatocyte fate. StemBook, ed. The Stem Cell Research Community, In StemBook. Cambridge, MA. doi/10.3824/stembook.1.52.1, http://www.stembook.org.
61.
MallannaSK and DuncanSA. (2013). Differentiation of hepatocytes from pluripotent stem cells. Curr Protoc Stem Cell Biol, 26:Unit 1G 4.
62.
TakayamaK, MorisakiY, KunoS, NagamotoY, HaradaK, FurukawaN, OhtakaM, NishimuraK, ImagawaK, et al. (2014). Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes. Proc Natl Acad Sci U S A, 111:16772–16777.
KnudsenS. (2004). Guide to Analysis of DNA Microarray Data, 2nd edn. John Wiley & Sons, Inc., Hoboken, NJ.
65.
International Stem Cell Initiative, AmpsK, AndrewsPW, AnyfantisG, ArmstrongL, AveryS, BaharvandH, BakerJ, BakerD, MunozMB, et al. (2011). Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol, 29:1132–1144.
66.
TsengYH, ButteAJ, KokkotouE, YechoorVK, TaniguchiCM, KriauciunasKM, CypessAM, NiinobeM, YoshikawaK, PattiME and KahnCR. (2005). Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat Cell Biol, 7:601–611.
67.
UsukiK, SarasJ, WaltenbergerJ, MiyazonoK, PierceG, ThomasonA and HeldinCH. (1992). Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun, 184:1311–1316.
68.
YoshimuraA, KuwazuruY, FurukawaT, YoshidaH, YamadaK and AkiyamaS. (1990). Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta, 1034:107–113.
69.
BottcherRT and NiehrsC. (2005). Fibroblast growth factor signaling during early vertebrate development. Endocr Rev, 26:63–77.
70.
LoebelDA and TamPP. (2012). Rho GTPases in endoderm development and differentiation. Small GTPases, 3:40–44.
71.
ShanJ, SchwartzRE, RossNT, LoganDJ, ThomasD, DuncanSA, NorthTE, GoesslingW, CarpenterAE and BhatiaSN. (2013). Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol, 9:514–520.
72.
NagaokaM, KobayashiM, KawaiC, MallannaSK and DuncanSA. (2015). Design of a vitronectin-based recombinant protein as a defined substrate for differentiation of human pluripotent stem cells into hepatocyte-like cells. PLoS One, 10:e0136350.
73.
TwaroskiK, MallannaSK, JingR, DiFurioF, UrickA and DuncanSA. (2015). FGF2 mediates hepatic progenitor cell formation during human pluripotent stem cell differentiation by inducing the WNT antagonist NKD1. Genes Dev, 29:2463–2474.
74.
SampaziotisF, Cardoso de BritoM, MadrigalP, BerteroA, Saeb-ParsyK, SoaresFA, SchrumpfE, MelumE, KarlsenTH, et al. (2015). Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation. Nat Biotechnol, 33:845–852.
75.
CaiJ, ZhaoY, LiuY, YeF, SongZ, QinH, MengS, ChenY, ZhouR, et al. (2007). Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology, 45:1229–1239.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
